2011
DOI: 10.1016/j.clon.2011.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Volumetric-modulated Arc Therapy in Head and Neck Radiotherapy: A Planning Comparison using Simultaneous Integrated Boost for Nasopharynx and Oropharynx Carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

8
54
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 76 publications
(64 citation statements)
references
References 24 publications
8
54
1
Order By: Relevance
“…As in the prostate VMAT planning studies, a universal finding in these studies was the reduction in MU (up to 46%) with VMAT plans compared with fixed field IMRT [91][92][93]. Many of the above studies used seven to nine fields in their fixed field IMRT plans which used a larger number of MUs compared with the five-field plans [91,92,95].…”
Section: Head and Neck Cancermentioning
confidence: 93%
See 1 more Smart Citation
“…As in the prostate VMAT planning studies, a universal finding in these studies was the reduction in MU (up to 46%) with VMAT plans compared with fixed field IMRT [91][92][93]. Many of the above studies used seven to nine fields in their fixed field IMRT plans which used a larger number of MUs compared with the five-field plans [91,92,95].…”
Section: Head and Neck Cancermentioning
confidence: 93%
“…Integral doses to the body were also lower in the VMAT plans by an average of 7% compared with the fixed field IMRT plans. A more recent planning study comparing VMAT with fixed field IMRT (SW) in nasopharyngeal and oropharyngeal cancer confirmed improved sparing of the contralateral parotid glands with comparable PTV coverage between the two techniques [93].…”
Section: Head and Neck Cancermentioning
confidence: 99%
“…RapidArc has been compared with IMRT for a number of sites and malignancies commonly treated by IMRT, including brain, head and neck, prostate, anal canal, and cervical uterine, and its advantages in target coverage, treatment-time efficiency, and organs at risk (OAR) sparing have been demonstrated [5][6][7][8][9][10]. CSI, on the other hand, represents a challenging site where treatment is still predominantly done with 3DCRT because of a lack of a systematic procedure for dealing with the disease using VMAT.…”
Section: Introductionmentioning
confidence: 99%
“…The use of VMAT in head and neck treatments may offer a combination of reduced treatment time, better organ‐at‐risk (OAR) sparing, or increased target dose conformality compared to other treatment types 2 , 3 , 4 , 5 . Many head and neck treatment plans include regional lymph nodes in the supraclavicular area.…”
Section: Introductionmentioning
confidence: 99%